The North American fluoroscopy devices market size was USD 2.02 Billion in 2022 and is likely to reach USD 3.05 Billion by 2031, expanding at a CAGR of 4.68% during 2023–2031. The growth of the market is attributed to increasing number of interventional radiology procedures that demand real-time imaging such as that in fluoroscopy.
Fluoroscopy designates to an imaging technique that uses X-rays to produce real-time images of internal organs. Unlike X-ray images, which are fixed still images on film, the fluoroscopy produces live moving pictures of internal organs, which can be viewed by the naked eye on a digital monitor. A fluoroscope has four components, which include an X-ray image intensifier, an X-ray source, an imaging system, and a work station.
The World Ageing 2019 report, anticipated that in 2019 there were about 53.340 million people aged 65 years or over in the United States. This number is expected to reach 70.842 million in 2030. As the number of the elderly population is projected to increase in the near future and this population is more prone to chronic conditions such as neurological disorders, cardiovascular, and other diseases which will show a positive impact on the market. Additionally, the American Heart Association Research claimed that, approximately 2,300 Americans die owing to cardiovascular diseases every day, an average of one death for every 38 seconds.
Integration of fluoroscopes with spectral shaping filter technology and advanced image intensifiers is believed to optimize the image-guided surgical procedures, thereby increasing their adoption by radiologists and surgeons.
The Covid-19 pandemic had a positive impact on the North American fluoroscopy devices market. The market observed rise in demand for fluoroscopy devices owing to high patient turnaround volume and frequent readmissions.
Market Trends, Drivers, Restraints, and Opportunities
-
Rising demand for minimally-invasive surgeries is expected to boost the fluoroscopy devices market.
-
Growing geriatric population and prevalence of chronic diseases are estimated to propel the market growth during the forecast period.
-
Increasing use of fluoroscopy in pain management is likely to fuel the demand for fluoroscopy equipment in coming years.
-
Rising side effects of radiation is projected to hinder the market growth over the forecast period.
-
R&D investment and technological advancement in the North American fluoroscopy devices market are expected to offer lucrative opportunities for the market players.
Scope of North American Fluoroscopy Devices Market Report
The report on North American fluoroscopy devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes
|
Details
|
Report Title
|
Fluoroscopy Devices Market - North American Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
Base Year
|
2022
|
Historic Data
|
2016–2021
|
Forecast Period
|
2023–2031
|
Segmentation
|
Device Type (Fixed Fluoroscopes and Mobile Fluoroscopes [Full-size Fluoroscopes and Mini Fluoroscopes), Application (Orthopedic, Cardiovascular, Pain Management and Trauma, Neurology, Gastrointestinal, Urology, General Surgery, and Others)
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
Key Players Covered in the Report
|
GE Healthcare (GE Company), Carestream Health, Canon Medical Systems Corporation, Siemens Healthineers and Koninklijke Philips NV
|
North American Fluoroscopy Devices Market Segment insights
The mobile fluoroscopes segment is projected to constitute a large market share
Based on device type, the North American fluoroscopy devices market is segregated into fixed fluoroscopes and mobile fluoroscopes. The mobile fluoroscopes are further divided into full-size fluoroscopes and mini fluoroscopes. The mobile fluoroscopes segment is expected to account for a key share of the market during the forecast period owing to its greater operator flexibility as the device can be moved wherever the fluoroscopic examination is needed.
The cardiovascular segment is expected to register a substantial CAGR
Based on application, the North American fluoroscopy devices market is divided into orthopedic, cardiovascular, pain management and trauma, neurology, sastrointestinal, urology, general surgery, and others.
The cardiovascular segment accounts for a key share of the market and is estimated to propel even further over the forecast period owing to increasing prevalence of cardiovascular diseases coupled with high demand for this equipment in cardiovascular imaging due to the appropriate intensity of its energy projections and technological advancements; however, the orthopedic segment is anticipated to expand at a rapid pace during the forecast period owing to high adoption of fluoroscopy equipments in orthopedic clinics, urgent care clinics, critical care, and imaging centers.
Segments
The North American fluoroscopy devices market has been segmented on the basis of:-
Device Type
- Fixed Fluoroscopes
- Mobile Fluoroscopes
- Full-size Fluoroscopes
- Mini Fluoroscopes
Application
- Orthopedic
- Cardiovascular
- Pain Management and Trauma
- Neurology
- Gastrointestinal
- Urology
- General Surgery
- Others
Key Companies
- GE Healthcare (GE Company)
- Carestream Health
- Canon Medical Systems Corporation
- Siemens Healthineers
- Koninklijke Philips NV
Competitive Landscape
Key players competing in the North American fluoroscopy devices market include GE Healthcare (GE Company), Carestream Health, Canon Medical Systems Corporation, Siemens Healthineers and Koninklijke Philips NV.
Some of these players are using several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares.